dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
Published 6 years ago • 297 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
0:53
dr. neelapu on next steps with kte-c19 in lymphoma
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
1:16
dr. neelapu on zuma-1 trial design of kte-c19
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
1:09
dr. neelapu discusses efficacy of axi-cel in large b-cell lymphoma
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
1:23
sattva neelapu, md, discusses efficacy results of the zuma-1 trial
-
0:32
sattva neelapu, md shares safety results of the zuma-1 trial in patients with nhl
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
6:03
clinical data for axi-cel in lymphoma
-
1:49
dr. jacobson on design of zuma-5 trial in r/r indolent non-hodgkin lymphoma
-
1:07
dr. winter discusses the zuma-7 trial in dlbcl
-
1:16
dr. brody on addressing resistance to immunotherapy in non-hodgkin lymphoma
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
1:22
dr. zonder on the zuma-2 and zuma-5 trials in mcl and inhl